Play Video
1
Will AstraZeneca
Will AstraZeneca's ticagrelor make Effient and Plavix obsolete?
::2009/10/02::
Play Video
2
Prasugrel and Ticagrelor in STEMI Patients
Prasugrel and Ticagrelor in STEMI Patients
::2013/04/10::
Play Video
3
Translating Ticagrelor
Translating Ticagrelor's Pharmacokinetics
::2013/05/17::
Play Video
4
Prasugrel y Ticagrelor en SCA
Prasugrel y Ticagrelor en SCA
::2012/06/20::
Play Video
5
Flash Lecture: Ticagrelor vs. Clopidogrel in Patients with Stroke or TIA
Flash Lecture: Ticagrelor vs. Clopidogrel in Patients with Stroke or TIA
::2012/03/12::
Play Video
6
Ticagrelor Trumps Clopidogrel for Vascular and Bleeding Outcomes
Ticagrelor Trumps Clopidogrel for Vascular and Bleeding Outcomes
::2012/09/27::
Play Video
7
BRILINTA (ticagrelor) Launches "Complete the Course"  ...
BRILINTA (ticagrelor) Launches "Complete the Course" ...
::2012/09/19::
Play Video
8
Uso del ticagrelor en el síndrome coronario agudo
Uso del ticagrelor en el síndrome coronario agudo
::2013/02/23::
Play Video
9
Ticagrelor Effects on MI Outcomes and Event Adjudication in PLATO
Ticagrelor Effects on MI Outcomes and Event Adjudication in PLATO
::2014/04/18::
Play Video
10
Why do I Use Ticagrelor in STEMI Patients | Elad Asher
Why do I Use Ticagrelor in STEMI Patients | Elad Asher
::2014/06/09::
Play Video
11
WEBM Dra  Camila Ramos nuevos antiagregantes ticagrelor y praugrel
WEBM Dra Camila Ramos nuevos antiagregantes ticagrelor y praugrel
::2014/04/21::
Play Video
12
Ticagrelor: de la teoría a la práctica. Experiencia de uso en el día a día. Dr. Radke
Ticagrelor: de la teoría a la práctica. Experiencia de uso en el día a día. Dr. Radke
::2012/10/19::
Play Video
13
Benefit of Ticagrelor in Plato - Clinical Implications
Benefit of Ticagrelor in Plato - Clinical Implications
::2013/05/16::
Play Video
14
Nuevo Antiagregantes: Prasugrel y Ticagrelor XIV Congreso SEMES CV
Nuevo Antiagregantes: Prasugrel y Ticagrelor XIV Congreso SEMES CV
::2011/11/29::
Play Video
15
Impatto della somministrazione di ticagrelor in ambulanza nei pazienti con infarto
Impatto della somministrazione di ticagrelor in ambulanza nei pazienti con infarto
::2014/09/06::
Play Video
16
hm_Apixaban, Ticagrelor Both Winners
hm_Apixaban, Ticagrelor Both Winners
::2013/01/08::
Play Video
17
The PLATO STEMI subanalysis: Will ticagrelor become the new go-to drug for antiplatelet therapy?
The PLATO STEMI subanalysis: Will ticagrelor become the new go-to drug for antiplatelet therapy?
::2010/04/30::
Play Video
18
The Effect of Ticagrelor in ACS -- Platelet and Non Platelet Dependent  Mechanisms | Doron Zahger
The Effect of Ticagrelor in ACS -- Platelet and Non Platelet Dependent Mechanisms | Doron Zahger
::2014/06/09::
Play Video
19
Over-the-Top Brilinta (ticagrelor) Pharma Display
Over-the-Top Brilinta (ticagrelor) Pharma Display
::2014/03/29::
Play Video
20
International Academy of Cardiology: Yochai Birnbaum, M.D.: TICAGRELOR LIMITS MYOCARDIAL
International Academy of Cardiology: Yochai Birnbaum, M.D.: TICAGRELOR LIMITS MYOCARDIAL
::2014/10/22::
Play Video
21
Ticagrelor Market Comprehensive Patent Search
Ticagrelor Market Comprehensive Patent Search
::2014/09/16::
Play Video
22
The PLATO CABG analysis: Another feather in the cap for ticagrelor?
The PLATO CABG analysis: Another feather in the cap for ticagrelor?
::2010/08/19::
Play Video
23
Platelet Adhesion and Aggregation  mechanism explained
Platelet Adhesion and Aggregation mechanism explained
::2011/09/29::
Play Video
24
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on ...
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on ...
::2013/08/05::
Play Video
25
Insidermedicine In 60 - January 13, 2010
Insidermedicine In 60 - January 13, 2010
::2010/01/14::
Play Video
26
GLOBAL LEADERS STUDY
GLOBAL LEADERS STUDY
::2013/05/16::
Play Video
27
CV drugs interaction
CV drugs interaction
::2014/02/11::
Play Video
28
Aterosclerosi e Trombosi - Meccanismi fisiopatologici e progressi clinici
Aterosclerosi e Trombosi - Meccanismi fisiopatologici e progressi clinici
::2013/01/16::
Play Video
29
7  Steg
7 Steg
::2014/04/03::
Play Video
30
ESC TV 2014 - ACUTE CORONARY SYNDROME
ESC TV 2014 - ACUTE CORONARY SYNDROME
::2014/09/17::
Play Video
31
The QAS Coronary Artery Reperfusion CPP
The QAS Coronary Artery Reperfusion CPP
::2014/04/29::
Play Video
32
Prof. Gilles Montalescot, Pitié-Salpetrière University Hospital (Paris, France)
Prof. Gilles Montalescot, Pitié-Salpetrière University Hospital (Paris, France)
::2014/09/01::
Play Video
33
FDA on the Brilinta approval
FDA on the Brilinta approval
::2011/07/26::
Play Video
34
High-Sensitivity Troponin as a Biomarker: A PLATO Substudy
High-Sensitivity Troponin as a Biomarker: A PLATO Substudy
::2012/12/17::
Play Video
35
Challenges for Post-PCI Antiplatelet Drugs
Challenges for Post-PCI Antiplatelet Drugs
::2012/04/23::
Play Video
36
Acute Coronary Syndromes at the European Society of Cardiology (ESC) Congress 2009
Acute Coronary Syndromes at the European Society of Cardiology (ESC) Congress 2009
::2009/09/16::
Play Video
37
Rachel Harris, question 3
Rachel Harris, question 3
::2013/02/25::
Play Video
38
Charité Clinical Journal Club by Fred Luft - 17.09.2014
Charité Clinical Journal Club by Fred Luft - 17.09.2014
::2014/09/19::
Play Video
39
Michael Callaghan, question 3
Michael Callaghan, question 3
::2013/02/27::
Play Video
40
Dr. Scott Wilson, question 3
Dr. Scott Wilson, question 3
::2013/02/25::
Play Video
41
Kim Kelly, question 3
Kim Kelly, question 3
::2013/02/25::
Play Video
42
Stephanie Young, question 3
Stephanie Young, question 3
::2013/02/25::
Play Video
43
F. Crea, G. Montalescot, P.W. Armstrong on the ATLANTIC study
F. Crea, G. Montalescot, P.W. Armstrong on the ATLANTIC study
::2014/10/20::
Play Video
44
Omg Atlanta
Omg Atlanta
::2014/02/14::
Play Video
45
Modulo SCACEST
Modulo SCACEST
::2014/04/08::
Play Video
46
Lipid Management for Secondary Prevention in Europe
Lipid Management for Secondary Prevention in Europe
::2013/05/17::
Play Video
47
Stephanie Young, question 4
Stephanie Young, question 4
::2013/02/25::
Play Video
48
ACUTE coronary sindrome
ACUTE coronary sindrome
::2014/02/27::
Play Video
49
Unmet needs in acute cardiac care Wijns&Clemmensen
Unmet needs in acute cardiac care Wijns&Clemmensen
::2013/10/07::
Play Video
50
Az akut coronaria sindroma kezelese - The treatment of acute coronary syndrom
Az akut coronaria sindroma kezelese - The treatment of acute coronary syndrom
::2009/11/01::
MAIS >>
RESULTADOS [51 .. 101]
Origem: Wikipédia, a enciclopédia livre.
Ir para: navegação, pesquisa
Ticagrelor
Alerta sobre risco à saúde
Ticagrelor.svg
Nome IUPAC (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-
3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-
hydroxyethoxy)cyclopentane-1,2-diol
Outros nomes AZD6140
Identificadores
Número CAS 274693-27-5
PubChem 9871419
Propriedades
Fórmula química C23H28F2N6O4S
Massa molar 522.55 g mol-1
Farmacologia
Via(s) de administração oral
Exceto onde denotado, os dados referem-se a
materiais sob condições normais de temperatura e pressão

Referências e avisos gerais sobre esta caixa.
Alerta sobre risco à saúde.

Ticagrelor (nome comercial Brilinta) é um fármaco inibidor da agregação plaquetária produzido pela AstraZeneca.[1]

Notas e referências

  1. RCM Pharma. Ticagrelor pertence a uma classe pioneira de medicamentos para tratamento antiplaquetário mais eficaz, proporcionando redução de eventos trombóticos em pacientes com síndrome coronariana aguda (SCA), também conhecidos como infarto ou angina instável (dor no peito). Painel da FDA com opiniões divergentes sobre o Brilinta® da AstraZeneca. Acesso em 29 de julho de 2010
Ícone de esboço Este artigo sobre fármacos é um esboço. Você pode ajudar a Wikipédia expandindo-o.
Conteúdo da Wikipedia está licenciado sob a: GFDL License
Powered by YouTube